07.08.2015
- Boehringer Ingelheim, the German drugmaker, has sold its US generics business for $2.7 billion to London-based Jordanian-British owned Hikima Pharmaceuticals. At the same time, it...
30.07.2015
- In the latest spectacular takeover to occupy the attention of the international pharmaceuticals sector, Israeli generics giant Teva has agreed to pay $40.5 billion cash and stock...
24.07.2015
- A US federal appeals court has ruled that Swiss drugmaker Novartis can begin selling Zarxio, its lower-cost generic version of an Amgen drug, on the US market starting in September...
09.06.2015
- Israeli generics giant Teva appears to be seeking alternative strategies for achieving its targeted acquisition of Netherlands-based Mylan, following the company’s rejection of its...
08.06.2015
- Perrigo has announced it will acquire a portfolio of branded over-the-counter drugs the UK’s largest pharmaceutical producer, GlaxoSmithKline (GSK) and Swiss drugs giant Novartis...
29.05.2015
- Just before trial proceedings were to begin in a long-running dispute between the US Federal Trade Commission (FTC) and drugmaker Cephalon - now a subsidiary of Teva - the Israeli...
28.05.2015
- Under a ruling by a US court of appeals upholding a preliminary injunction dating from December 2014, Ireland-headquartered former US drugmaker Actavis will have to continue...
15.05.2015
- India-based generics producer Dr Reddy's Laboratories is pleased with its performance in fiscal 2015 (March 31) achieved despite currency volatility in some emerging market...
